hotspot -WSS

hotspot

author：Wikipedia 2025-09-07 06:42:24 - browse：71185

James Comer (R-KY) walks on the House side of the U.S. Capitol on May 14, 2024 in Washington, DC — Rep. James Comer (R-Ky.), the chair of the House Committee on Oversight and Accountability, has taken an interest in pharmacy benefit managers. Kent Nishimura/Getty Images

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT.

Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

The committee and companies did not respond to requests for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Senators tussle over abortion against the backdrop of a presidential campaign

focus

WSS

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Listen: Vivek Ramaswamy's star turn & leaky drug data

The most pressing bird flu mysteries scientists want answered

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

How the first Native Hawaiian psychiatrist helped diversify medicine

CDC says it’s too soon to assess risk posed by Covid subvariant

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Medicare proposal to cover medical devices draws a mixed reaction

Senators tussle over abortion against the backdrop of a presidential campaign

In age of alternative facts, a scholarly course on calling out crap

UnitedHealth CEO's Medicaid comments send insurer stocks diving

How to save PrEP access — and even expand it

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Dobbs anniversary: the lost opportunity of abortion as health care

As obesity drug market grows, telehealth companies court payers

Moonlake's readout produced a cash windfall. Risks remain

FTC loses bid to block Novant's North Carolina hospital merger

Wikipedia

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

For pregnant people, addiction treatment shouldn't mean a call to child protective services

ASCO Takeaways: Winners, snoozers, and the art of cancer care

Health officials lay out plans to cope with respiratory virus season

Kellogg’s is going to war over Mexico’s nutrition label rules

For pregnant people, addiction treatment shouldn't mean a call to child protective services

explore

focus

focus

focus